Pain relief medicine franchise in Ahmedabad

Anti-inflammatory tablet supplier in Mumbai

Orthopedic medicine distributor in Delhi

Diclofenac Paracetamol Serratiopeptidase tablet manufacturer in Bangalore

Pain management medicine stockist in Hyderabad
Musculoskeletal medicine exporter in Chandigarh

Home/Products /diclofenac-50mg-paracetamol-325mg-serratiopeptidase-15mg-tablet

About the Product

Description


Decplist SP 15 Tablet containing Diclofenac, Paracetamol, and Serratiopeptidase is used for the management of pain, inflammation, and swelling associated with musculoskeletal and post-injury conditions. It helps reduce discomfort and supports faster recovery.

Diclofenac works as a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation, Paracetamol provides analgesic and antipyretic action, while Serratiopeptidase helps reduce swelling and promotes healing.

The tablet is widely prescribed in orthopedic, dental, and general medicine practice for pain, trauma, and inflammatory conditions, leading to consistent prescription demand.

With increasing prevalence of musculoskeletal disorders and growing demand for multi-action pain relief therapies, this product offers strong business potential for retailers and distributors. Its triple-action formulation, established clinical relevance, and steady market demand make it a reliable product for growth in the pain management segment.

Some patients may experience nausea, vomiting, stomach pain, heartburn, dizziness, headache, or diarrhea. Rarely, gastrointestinal bleeding, liver enzyme elevation, allergic reactions, or kidney impairment may occur and require immediate medical attention.

Decplist SP 15 Tablet is indicated for musculoskeletal pain, joint pain, dental pain, postoperative pain, sprains, strains, arthritis, and other inflammatory conditions associated with swelling and discomfort. It helps reduce pain intensity, inflammation, and tissue swelling.

This medicine should be used strictly under medical supervision. Avoid alcohol and use cautiously in patients with liver disease, kidney impairment, peptic ulcer disease, or cardiovascular disorders. Do not exceed the recommended dose of Paracetamol to prevent liver toxicity.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Diclofenac 50mg + Paracetamol 325mg + Serratiopeptidase 15mg Tablet in the PCD pharma franchise market?

This combination has strong demand in the orthopedic, pain management, dental, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on analgesic, anti-inflammatory, and post-injury care portfolios.

Why should medical distributors include Diclofenac + Paracetamol + Serratiopeptidase Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for pain, inflammation, and swelling management under medical supervision. Diclofenac 50mg is a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation Paracetamol 325mg provides additional analgesic and antipyretic (fever-reducing) action Serratiopeptidase 15mg is an enzyme that helps reduce inflammation, swelling, and promotes healing Commonly prescribed for musculoskeletal pain, post-operative pain, dental pain, injuries, sprains, and inflammatory conditions Provides triple-action relief for faster recovery and improved patient comfort This strengthens a comprehensive pain management and orthopedic care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Diclofenac 50mg + Paracetamol 325mg + Serratiopeptidase 15mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong demand in orthopedics and general medicine practice, repeat prescriptions, high market acceptance, reliable supply chain support, and attractive margins in the pain management segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.